ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
• Victoria’s Secret shares slump 16% on weak Q3 operating income outlook